Aurinia Pharmaceuticals Inc (AUPH)
7.295
-0.14
(-1.95%)
USD |
NASDAQ |
Oct 03, 16:00
7.295
0.00 (0.00%)
After-Hours: 16:11
Aurinia Pharmaceuticals Total Assets (Quarterly): 548.90M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 548.90M |
| March 31, 2023 | 451.76M |
| December 31, 2022 | 470.86M |
| September 30, 2022 | 488.29M |
| June 30, 2022 | 482.15M |
| March 31, 2022 | 506.90M |
| December 31, 2021 | 543.37M |
| September 30, 2021 | 360.07M |
| June 30, 2021 | 386.27M |
| March 31, 2021 | 417.08M |
| December 31, 2020 | 463.66M |
| June 30, 2020 | 295.28M |
| March 31, 2020 | 314.97M |
| December 31, 2019 | 324.30M |
| September 30, 2019 | 150.84M |
| June 30, 2019 | 151.24M |
| March 31, 2019 | 164.50M |
| December 31, 2018 | 145.86M |
| September 30, 2018 | 157.70M |
| June 30, 2018 | 167.86M |
| March 31, 2018 | 176.41M |
| December 31, 2017 | 189.85M |
| September 30, 2017 | 199.83M |
| June 30, 2017 | 207.80M |
| March 31, 2017 | 219.69M |
| Date | Value |
|---|---|
| December 31, 2016 | 57.00M |
| September 30, 2016 | 33.25M |
| June 30, 2016 | 30.19M |
| March 31, 2016 | 27.75M |
| December 31, 2015 | 33.57M |
| September 30, 2015 | 38.94M |
| June 30, 2015 | 44.38M |
| March 31, 2015 | 48.01M |
| December 31, 2014 | 52.38M |
| September 30, 2014 | 56.40M |
| June 30, 2014 | 60.18M |
| March 31, 2014 | 63.28M |
| December 31, 2013 | 23.17M |
| September 30, 2013 | 23.33M |
| June 30, 2013 | 3.874M |
| March 31, 2013 | 3.644M |
| December 31, 2012 | 4.158M |
| September 30, 2012 | 7.740M |
| June 30, 2012 | 9.004M |
| March 31, 2012 | 9.739M |
| December 31, 2011 | 14.32M |
| September 30, 2011 | 20.12M |
| June 30, 2011 | 19.34M |
| March 31, 2011 | 15.14M |
| December 31, 2010 | 10.28M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
145.86M
Minimum
Dec 2018
548.90M
Maximum
Jun 2023
370.35M
Average
401.67M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 73.03M |
| Edesa Biotech Inc | 9.420M |
| Lexaria Bioscience Corp | 5.240M |
| Liminal Biosciences Inc | 23.99M |
| Xenon Pharmaceuticals Inc | 684.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 156.61M |
| Shareholders Equity (Quarterly) | 392.29M |
| Current Ratio | 6.745 |